Skip to main content
Log in

The pattern of urinary acylcarnitines determined by electrospray mass spectrometry: a new tool in the diagnosis of diabetes mellitus

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

l-Carnitine and its esters are products of intermediary metabolism of organisms. The distribution pattern or the favored excretion of individual acylcarnitines tells something about metabolic diseases. The determination of the urinary acylcarnitine pattern by flow injection analysis (FIA)–electrospray ionization (ESI)–mass spectrometry (MS) is presented. Groups of healthy probands and patients suffering from diabetes mellitus were investigated due to their significant acylcarnitine profile. The statistical analysis of data sets obtained clearly shows a difference in the acylcarnitine pattern of healthy and sick probands. In comparison to the controls, diabetes mellitus patients excrete more long-chain carnitine esters ranging from dodecanoyl to palmitoylcarnitine. Thus, the urinary acylcarnitine pattern determined by ESI–MS can be a useful tool in the diagnosis and therapy monitoring of diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.
Fig. 10.
Fig. 11.

Similar content being viewed by others

Abbreviations

ANOVA:

analysis of variance

ATP:

adenosine triphosphate

APCI:

atmospheric pressure chemical ionization

BMI:

body mass index

CoA:

coenzyme A

CPT:

carnitine palmitoyltransferase

ESI:

electrospray ionization

FIA:

flow injection analysis

LC:

long-chain

LC–FFA:

long-chain free fatty acid

LCA:

long-chain acylcarnitines

MALDI–TOF:

matrix-assisted laser desorption ionization–time-of-flight mass spectrometry

MCAD:

medium-chain acyl CoA dehydrogenase deficiency

MID:

multi ion detection

MCA:

medium-chain acylcarnitines

MS:

mass spectrometry

SCA:

short-chain acylcarnitines

References

  1. Lehnert H, Schuster HP (eds) (1998) Innere Medizin. Enke Verlag, Stuttgart, p 117; Harper P, Wadstrom C, Cederblad G (1993) Clin Chem 39:592

    PubMed  Google Scholar 

  2. Chace DH, Hillman SH, Millington DS, Kahler SG, Adam BW, Levy HL (1996) Clin Chem 42:349–355

    CAS  PubMed  Google Scholar 

  3. Millington DS, Chace DH, Hillman SL, Kodo N, Terada N (1994) In: Matsuo T, Seyama Y, Caprioli RM, Gross ML (eds) Biological mass spectrometry: present and future. Wiley, pp 559–579

  4. Rashed MS, Ozand PT, Bucknall MP, Little D (1995) Pediatr Res 38:324–331

    CAS  PubMed  Google Scholar 

  5. Chace DH, Hillman SL, van Hove JLK, Naylor EW (1997) Clin Chem 43:2106–2113

    CAS  PubMed  Google Scholar 

  6. Millington DS, Chace DH (1992) Mass spectrometry-clinical and biomedical applications. Plenum, New York

  7. Rashed MS, Bucknall MP, Little D, Awad A, Jacob M, Alamoudi M, Alwattar M, Ozand PT (1997) Clin Chem 43:1129–1139

    CAS  PubMed  Google Scholar 

  8. Heinig K, Henion J (1999) J Chromatogr B 735:171–188; Kiessig S, Vogt C, Werner G (1997) J Chromatogr A 781:457–466

    Article  Google Scholar 

  9. Kamimori H, Hamashima Y, Konishi M (1994) Anal Biochem 218:417–429

    Article  CAS  PubMed  Google Scholar 

  10. Vanhove JLK, Zhang W, Kahler SG, Roe CR, Chen YT, Terada N, Chace DH, Iafolla AK, Ding JH, Millington DS (1993) Am J Hum Genet 52:958

    CAS  PubMed  Google Scholar 

  11. Löster H, Müller DM (1995) Wiss Z Karl-Marx-Univ, Math-Naturwiss R 34:212–223

  12. McGarry JD, Foster DW (1976) J Lipid Res 17:277–281

    CAS  PubMed  Google Scholar 

  13. Schmidt–Sommerfeld E, Zhang L, Bobrowski PJ, Penn D (1995) Anal Biochem 231:27; Minkler PE, Hoppel CE (1993) J Chromatogr 613:203

    PubMed  Google Scholar 

  14. Kamimori H, Hamashima Y, Konishi M (1994) Anal Biochem 218:417; Kumps A, Duez P, Mardens Y (1994) J Chromatogr B 658:241

    Google Scholar 

  15. Möder M, Löster H, Herzschuh R, Popp P (1997) J Mass Spectrom 32:1195

    CAS  PubMed  Google Scholar 

  16. Hardy DT, Hall SK, Morris M, Green A (1999) Application of tandem mass spectrometry (MS-MS) to neonatal screening for phenylketonuria (PKU) in a UK laboratory, 14th national neonatal screening symposium

  17. Angelini C, Vergani L, Costa L, Martinuzzi A, Dunner E, Marescotti C, Nosadini R (1986) Adv Clin Enzym 4:103–110

    CAS  Google Scholar 

  18. Cooper MB, Jones DA, Edwards RHT, Corbucci GC, Montanari G, Trevisani C (1986) J Sports Sci 4:79–87

    CAS  PubMed  Google Scholar 

  19. Soop M, Björkman O, Cederblad G, Hagenfeldt L, Wahren J (1988) Eur J Appl Physiol 64:2394-2399

    CAS  Google Scholar 

  20. Mc Garry JD (1998) Am J Clin Nutr 67 (3 Suppl):500S–504S

  21. Pregant P, Schernthaner G, Legenstein E, Lienhardt L, Bruck S, Schnack C, Kaiser E (1991) Klin Wochenschr 69:511–516

    CAS  PubMed  Google Scholar 

  22. Möder M, Kießling A, Löster H (2002) The pattern of urinary acylcarnitines determined by electrospray mass spectrometry characterization of cardiomyopathy and effects of l-carnitine substitution (in preparation)

Download references

Acknowledgement

The authors thank Mrs Zirkler for performing the radiolabeled enzyme assay.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Möder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möder, M., Kießling, A., Löster, H. et al. The pattern of urinary acylcarnitines determined by electrospray mass spectrometry: a new tool in the diagnosis of diabetes mellitus . Anal Bioanal Chem 375, 200–210 (2003). https://doi.org/10.1007/s00216-002-1654-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-002-1654-7

Keywords

Navigation